AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DNovalis LifeSciences Investments II, L.P. • June 15th, 2023 • Laboratory analytical instruments
The undersigned being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, as amended, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
